This is an update to our article of 14 February 2019.

Effective from 1 March 2019 PHARMAC will list Flucon in the Pharmaceutical Schedule Fully Funded.

Providing supplies of the new temporary listing are readily available then the FML allocation may be removed.

Please note ProPharma / PWR will sell through existing supplies of FML prior to releasing stock of Flucon and that at the time that FML is able to be resupplied we will sell through all Flucon before releasing FML.

We thank you in anticipation of your ongoing support.

About The Author